查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912606

血液处理和储存设备市场（按产品类型、技术、最终用户和分销管道划分）—2026-2032年全球预测

Blood Processing & Storage Equipment Market by Product Type, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血液处理和储存设备市场价值将达到 55.2 亿美元，到 2026 年将成长至 58.6 亿美元，到 2032 年将达到 91.5 亿美元，年复合成长率为 7.48%。

关键市场统计数据
基准年 2025 55.2亿美元
预计年份：2026年 58.6亿美元
预测年份 2032 91.5亿美元
复合年增长率 (%) 7.48%

从临床、监管和技术角度来看，血液处理和储存设备亟需成为现代输血和医疗服务的核心基础设施。

目前血液处理和储存设备的现况正处于临床需求、技术创新和监管三者交汇点。随着细胞疗法、精准输血实践和复杂诊断技术被整合到临床路径中，支持血液采集、分离、储存和配送的设备在安全有效地提供医疗保健服务方面发挥着日益重要的作用。近年来，人们逐渐认识到，稳健的供应链、可靠的低温运输完整性和自动化处理平台能够直接改善患者预后并帮助医疗机构控製成本。因此，从血站到医院再到研究机构，相关人员都在优先投资于能够减少人为操作差异、提升处理能力以及保障血液产品从采集到输血或治疗用途全程完整性的领域。

自动化、数位化可追溯性、分散式处理、永续性需求以及服务主导商业模式如何重塑血液处理和储存运营

市场正经历着由自动化、数位化和医疗服务模式变革所驱动的转型，这些因素共同重塑了血液製品的采集、处理和储存方式。自动化降低了分离和成分配製过程中的变异性，提高了可重复性，并减少了对操作人员的依赖。同时，数位化平台增强了从捐血到受体的可追溯性，有助于监管合规和不利事件调查。这些技术进步正将营运模式从纯粹的集中式处理转向混合模式，这种模式兼顾了能够进行大批量处理的集中式设施和以照护现场和分散性为核心的床边/区域处理单元。

评估近期关税调整如何强化了医疗设备采购中来源多元化、在地化生产策略和采购韧性的必要性

近期关税措施和贸易政策的变化为医疗设备（包括血液处理和储存设备及耗材）的筹资策略带来了新的复杂性。进口课税和关税调整推高了关键零件的到岸成本，促使采购团队重新评估其供应商组合併考虑其他筹资策略。为此，许多相关人员正在重组其供应链，透过供应商多元化、认证区域製造商以及增加关键耗材的库存缓衝来维持医疗服务的连续性。虽然这种以库存为中心的应对措施有助于缓解短期中断，但也增加了营运资金需求并加剧了仓储能力的压力，从而影响了营运计画。

深入的细分市场分析揭示了产品、最终用户、技术和分销维度如何影响整个医疗保健领域的采购、监管和营运选择。

细分市场的特定特征会影响产品、终端用户、技术和分销管道等各个层面的需求、技术应用和商业策略。基于产品类型，分析涵盖了血球分离设备、血袋和血袋套装、采血管、血型鑑定试剂、血浆分离器和储存容器。在血球分离领域，粒细胞分离、血浆分离和血小板分离之间的区别导致了处理量、一次性耗材使用量和监管要求的差异。血袋和相关套装的配置从单袋到双袋、三袋和四袋不等，每种配置都会影响工作流程效率、成分产量和库存管理。采血管根据添加剂的化学成分和用途进行分类，包括用于血液凝固检验的柠檬酸盐采血管、用于血液学检测的EDTA采血管和用于血清学检测的凝胶分离管，每种类别都有不同的储存和处理要求。血型鑑定试剂分为ABO血型试剂、抗体筛检试剂和Rh因子试剂，这些试剂的分类决定了检测流程、试剂生命週期管理以及输血服务供应链的重要性。血浆分离设备主要分为离心分离系统和过滤分离系统，二者的差异在于处理量、剪切力暴露程度以及对不同血浆衍生产品的适用性。储存容器的选择取决于稳定性要求、低温运输物流以及血液製品的最终用途，并根据常温和冷藏储存方案进行评估。

区域比较观点：揭示监管复杂性、基础设施成熟度和製造业政策如何影响全球设备采用和供应策略

区域趋势对技术采纳、监管时间表和供应链设计有显着影响，美洲、欧洲、中东和非洲以及亚太地区呈现出截然不同的模式。在美洲，医疗保健系统倾向于优先考虑在大规模集中式设施中扩展和整合处理基础设施，同时投资于自动化和数位化可追溯性，以支援广泛的全国性网路。采购週期可能受到集中式合约和报销框架的影响，这促使供应商优先考虑强大的服务网络和合规认证。同时，欧洲、中东和非洲呈现出多元化的格局，成熟的法规结构与资源受限的环境并存。这不仅催生了对高端自动化平台的需求，也催生了对能够满足基本安全性和可追溯性要求的、适应性强且成本低廉的解决方案的需求。该地区多司法管辖区的复杂监管环境凸显了在地化监管专业知识和灵活产品线的价值。

产品和服务整合、临床检验、监管专业知识以及可互通的数位化解决方案将如何决定该领域的竞争优势和客户维繫

血液处理和储存设备领域的竞争更取决于持续的服务关係、监管信誉以及在硬体、耗材和软体方面的创新能力，而非一次性交易。主要企业优先投资于仪器、检验的耗材和全生命週期服务的整合产品组合，以建立长期的营运伙伴关係。策略差异化因素包括：支援仪器性能的深度临床检验数据、覆盖范围广以最大限度降低停机风险的服务网络，以及符合当地监管要求的良好记录。此外，提供灵活商业模式（例如管理服务、试剂服务和按绩效付费合约）的公司，对于寻求可预测营运预算和降低资本风险的大型机构买家而言，也越来越具有吸引力。

对领导者而言，在血液处理技术领域，提升韧性、临床价值和竞争差异化能力，是策略、营运和商业性的当务之急。

为维持竞争力及临床相关性，产业领导者应采取多管齐下的策略，整合采购弹性、产品创新及终端用户价值。首先，他们应优先考虑供应商多元化和选择区域性製造合作伙伴，以降低贸易政策波动和关税带来的成本波动风险。同时，应结合基于情境的库存规划和合约机制，与供应商分担关税风险。其次，他们应加快对自动化和资料互通性的投资，以减少人为操作差异、增强可追溯性并满足监管报告要求。这些投资应辅以结构化的培训计画和持续改善机制，以确保实现临床效益。

我们采用混合方法检验研究途径，结合关键相关人员访谈、监管和技术分析以及严格的检验，以提供可操作的策略见解。

我们的研究途径结合了定性和定量方法，旨在建立一个稳健且多角度的血液处理和储存生态系统视图。主要研究包括对采购主管、临床实验室主任、输血服务经理和医疗设备工程师进行结构化检验，以了解实际挑战、实施驱动因素和采购标准。此外，我们也与生产和分销主管进行面对面交流，以了解供应链策略、产品蓝图和服务模式。次要研究则利用监管文件、技术标准、製造商文件和同行评审文献，来检验产品性能声明、灭菌和储存要求以及技术规范。

整合营运、技术和策略主题，强调临床上对整合解决方案、采购弹性以及可追溯的自动化工作流程的需求。

综合评估显示，血液处理和储存设备正从通用硬体转变为整合自动化、检验的耗材和数位化追踪的临床基础设施。营运重点正转向降低变异性、确保低温运输全程的产品完整性以及确保快速获得备件和服务。筹资策略必须透过多元化采购管道、选择区域供应商以及在采购合约中加入服务和保固条款来适应地缘政治和关税压力。技术趋势表明，自动化和互通性将进一步发展，而细分市场的差异则表明，产品特性和最终用户的特定需求将显着影响产品的采用时间和价值实现。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的血液处理和储存设备市场

  • 血液分离机
    • 粒细胞分离术
    • 血浆置换
    • 血小板分离术
  • 血袋和血包
    • 双血袋
    • 单血袋
    • 三袋和四袋血袋
  • 采血管
  • 血型鑑定试剂
  • 等离子分离器
  • 储存容器

9. 按技术分類的血液处理和储存设备市场

  • 自动化
  • 手动的
  • 半自动

第十章 依最终用户分類的血液处理和储存设备市场

  • 血库
  • 诊断检查室
  • 医院
  • 研究所

第十一章 按分销管道分類的血液处理和储存设备市场

  • 直销
  • 经销商
  • 在线的

第十二章：血液处理和储存设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 血液处理与储存设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国血液处理及储存设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国血液处理与储存设备市场

第十六章 中国血液处理与储存设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • BioLife Solutions, Inc.
  • Cerus Corporation
  • Danaher Corporation
  • Fresenius Kabi AG
  • Grifols, SA
  • Haemonetics Corporation
  • PHC Holdings Corporation
  • Sebia, Inc.
  • StemCyte Inc.
  • Stirling Ultracold
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • ThermoGenesis Holdings, Inc.
  • Vita 34 AG
Product Code: MRR-AE420CB13A57

The Blood Processing & Storage Equipment Market was valued at USD 5.52 billion in 2025 and is projected to grow to USD 5.86 billion in 2026, with a CAGR of 7.48%, reaching USD 9.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.52 billion
Estimated Year [2026] USD 5.86 billion
Forecast Year [2032] USD 9.15 billion
CAGR (%) 7.48%

Framing the urgent clinical, regulatory, and technological drivers that make blood processing and storage equipment core infrastructure for modern transfusion and therapy delivery

The landscape of blood processing and storage equipment sits at the intersection of clinical necessity, technological innovation, and regulatory scrutiny. As clinical pathways evolve to include more cellular therapies, precision transfusion practices, and complex diagnostics, the equipment that underpins collection, separation, storage, and distribution becomes increasingly central to safe and effective care delivery. Recent years have underscored how resilient supply chains, robust cold chain integrity, and automated processing platforms contribute directly to patient outcomes and institutional cost control. Consequently, stakeholders from blood centers to hospitals and research institutes are prioritizing investments that reduce manual variability, increase throughput, and protect product integrity from collection through to transfusion or therapeutic use.

In parallel, regulatory agencies and accreditation bodies are tightening expectations around traceability, sterility, and validated storage conditions. These expectations are catalyzing a shift from legacy manual workflows toward integrated solutions that combine instrument-level automation with data capture and interoperability. The result is a market dynamic in which manufacturers must not only deliver reliable hardware but also embed software, service, and lifecycle management capabilities. For decision-makers, the imperative is clear: evaluate equipment on total cost of ownership and clinical risk reduction, prioritize vendor ecosystems that offer end-to-end support, and plan procurement cycles with a focus on modularity and future-proofing. This introduction frames the criticality of treating blood processing and storage equipment not as isolated capital purchases but as foundational infrastructure for modern transfusion and therapeutic workflows.

How automation, digital traceability, decentralized processing, sustainability imperatives, and service-led commercial models are reshaping blood handling and storage operations

The market is undergoing transformative shifts driven by automation, digitalization, and changing care delivery models that together redefine how blood products are collected, processed, and stored. Automation is reducing variability in separation and component preparation, thereby improving reproducibility and lowering operator dependence. At the same time, digital platforms are enabling richer traceability from donor to recipient, which supports both regulatory compliance and adverse event investigation. These technological advances are fostering an operational move away from purely centralized processing toward hybrid models that balance high-volume central facilities with point-of-care or regional processing units where immediacy and decentralization matter most.

Concurrently, industry stakeholders are re-evaluating single-use consumables and closed-system designs to mitigate contamination risk and streamline workflow. Sustainability considerations are prompting design changes in materials, energy use, and cold chain logistics. Strategic partnerships and service-oriented commercial models are emerging as manufacturers seek to offer lifecycle value rather than transactional sales. Finally, the growing importance of plasma-derived therapies and cellular products has elevated the role of specialized separation technologies and validated cold storage systems. Taken together, these shifts mean that buyers increasingly expect integrated solutions that blend equipment, consumables, software, and service-creating an environment where innovation, regulatory alignment, and commercial agility determine market leadership.

Assessing how recent tariff realignments have reinforced the need for supplier diversification, regional production strategies, and procurement resilience in medical device sourcing

Recent tariff actions and trade policy shifts have introduced new layers of complexity to procurement strategies for medical equipment, including machines and consumables used in blood processing and storage. Import levies and tariff realignments can elevate landed costs for key components, prompting procurement teams to re-evaluate vendor portfolios and consider alternative sourcing strategies. In response, many stakeholders are recalibrating supply chains by diversifying suppliers, qualifying regional manufacturers, and increasing inventory buffers for critical consumables to maintain continuity of care. This inventory-centric response helps mitigate short-term disruption, but it also elevates working capital requirements and stresses storage capacity, which in turn affects operational planning.

Beyond immediate procurement impacts, tariffs can influence longer-term supplier decisions and investment flows. Manufacturers may accelerate regional production or assembly to avoid tariff exposure, which can benefit local industry but requires time and capital to realize. Regulatory and quality assurance processes often slow nearshoring efforts, so organizations must weigh the benefits of reduced trade friction against the certification and validation timelines inherent in medical device manufacture. Additionally, procurement teams are increasingly incorporating tariff sensitivity analysis into tender evaluations, factoring potential duty changes into contract terms and supplier performance clauses. Overall, the cumulative effect of tariff policy shifts encourages a more resilient, diversified supply strategy that balances cost, compliance, and continuity-while underscoring the strategic value of adaptable sourcing and robust supplier partnerships.

In-depth segmentation analysis revealing how product, end-user, technology, and distribution dimensions determine procurement, regulatory, and operational choices across the care continuum

Segment-specific dynamics shape demand, technology adoption, and commercial strategy across the product, end user, technology, and distribution channel dimensions. Based on product type, analysis covers apheresis equipment, blood bags and sets, blood collection tubes, grouping reagents, plasma separation equipment, and storage containers. Within apheresis, distinctions among granulocyte apheresis, plasma apheresis, and platelet apheresis drive different throughput, disposables usage, and regulatory expectations. Blood bags and associated sets vary by configuration, from single to double to triple and quadruple systems, each influencing workflow efficiency, component yield, and inventory management. Blood collection tubes are categorized by additive chemistry and use case, including citrate tubes for coagulation studies, EDTA tubes for hematology, and gel separator tubes for serum-based testing, and each category imposes distinct storage and handling requirements. Grouping reagents span ABO, antibody screening, and Rh reagents, which together dictate testing algorithms, reagent lifecycle management, and supply chain criticality for transfusion services. Plasma separation equipment differs fundamentally across centrifuge systems and filtration systems, affecting throughput, shear exposure, and suitability for different plasma-derived products. Storage containers are evaluated across ambient and refrigerated solutions, with choice driven by stability requirements, cold chain logistics, and the intended end use of the blood product.

Based on end user, the market perspective shifts among blood banks, diagnostic laboratories, hospitals, and research institutes, each of which has unique purchasing cycles and operational priorities. Blood banks focus on component yield, donor throughput, and traceability, while diagnostic laboratories emphasize tube chemistry consistency and sample integrity for downstream testing. Hospitals require integrated solutions that align with transfusion services and patient care pathways, and research institutes often seek customizable platforms that support method development and experimental validation. Based on technology, adoption patterns between automated, manual, and semi-automated systems influence staff training requirements, throughput scalability, and error rates. Automated systems reduce operator variability and facilitate data capture, whereas manual workflows remain relevant in low-volume or resource-constrained settings; semi-automated options often serve as compromise solutions where partial mechanization yields meaningful efficiency gains. Finally, based on distribution channel, direct sales, distributors, and e-commerce channels each deliver different levels of service, contractual complexity, and local regulatory support. Direct sales can provide tight integration with clinical service teams and bespoke service agreements, while distributors offer local reach and inventory support, and e-commerce channels increase access for standardized consumables and low-complexity items. Understanding the interplay among these segmentation axes is essential to aligning product development, go-to-market strategy, and supply chain design with the needs of diverse customer archetypes.

Comparative regional perspectives showing how regulatory complexity, infrastructure maturity, and manufacturing policies shape equipment adoption and supply strategies worldwide

Regional dynamics materially influence technology adoption, regulatory timelines, and supply chain design, with distinct patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, healthcare systems tend to emphasize scale and consolidation of processing infrastructure in larger central facilities while also investing in automation and digital traceability to support broad national networks. Procurement cycles can be influenced by centralized contracting and reimbursement frameworks, leading suppliers to prioritize robust service networks and compliance credentials. In contrast, Europe, Middle East & Africa presents a heterogeneous picture in which mature regulatory frameworks coexist with resource-constrained settings, creating demand for both high-end automated platforms and adaptable, lower-cost solutions that meet basic safety and traceability requirements. Multi-jurisdictional regulatory complexity in this region increases the value of localized regulatory expertise and flexible product lines.

Asia-Pacific exhibits rapid adoption of both centralized and decentralized models driven by population scale, expanding healthcare infrastructure, and strategic investments in domestic manufacturing capacity. Demand patterns often emphasize cost-efficiency and scalability, while governments may support nearshoring initiatives that reduce import dependencies. Across all regions, cold chain integrity remains a universal priority, but the logistical challenges and infrastructure investments required to maintain refrigerated storage and transport vary substantially. In addition, regional variations in clinical practice patterns, blood donation rates, and therapeutic priorities shape product preferences and the relative importance of consumables versus capital equipment. For organizations operating cross-regionally, success depends on tailoring go-to-market approaches to local procurement processes, regulatory environments, and service expectations while ensuring global standards for quality and traceability are upheld.

How product-service integration, clinical validation, regulatory expertise, and interoperable digital offerings define competitive advantage and customer retention in this sector

Competitive dynamics in the blood processing and storage equipment space are defined less by one-time transactions and more by enduring service relationships, regulatory credibility, and the ability to innovate across hardware, consumables, and software. Leading organizations tend to invest in integrated portfolios that combine instruments with validated consumables and lifecycle services, thereby locking in long-term operational partnerships. Strategic differentiators include the depth of clinical validation data supporting device performance, the breadth of service networks that minimize downtime risk, and demonstrated adherence to regional regulatory requirements. Additionally, companies that offer flexible commercial models-such as managed services, reagent-as-a-service, or outcome-linked agreements-are increasingly attractive to large institutional buyers seeking predictable operational budgets and reduced capital exposure.

Collaboration between manufacturers and end users is accelerating product refinement cycles, with field feedback informing consumable design, usability improvements, and software interoperability. Firms that prioritize interoperability with hospital information systems and laboratory information management systems gain advantage in procurement evaluations that emphasize data integrity and traceability. Finally, investment in training and technical support is a critical competitive lever; vendors that can demonstrate rapid response times, strong parts availability, and deployment support for validation and change management typically maintain higher retention and referral rates among hospital transfusion services and centralized blood centers.

Strategic, operational, and commercial imperatives for leaders to enhance resilience, clinical value, and competitive differentiation in blood handling technologies

Industry leaders should adopt a multifaceted strategy that aligns procurement resilience, product innovation, and end-user value to remain competitive and clinically relevant. First, prioritize supplier diversification and qualification of regional manufacturing partners to reduce exposure to trade policy shocks and tariff-driven cost volatility. This should be paired with scenario-based inventory planning and contractual mechanisms that share tariff risk with suppliers. Second, accelerate investments in automation and data interoperability to reduce manual variability, enhance traceability, and support regulatory reporting requirements. These investments must be accompanied by structured training programs and continuous improvement pathways to ensure realized clinical benefits.

Third, reframe commercial offerings toward lifecycle value by bundling equipment with validated consumables, preventative maintenance, and outcome-based service agreements. This approach not only stabilizes revenue streams but also aligns incentives between supplier and end user around uptime and clinical performance. Fourth, embed sustainability into product design and logistics planning to reduce environmental impact and respond to institutional procurement mandates. Finally, cultivate close partnerships with clinical and laboratory stakeholders to co-develop solutions, accelerate clinical validation, and streamline regulatory submissions. Taken together, these recommendations help manufacturers and buyers reduce operational risk, improve patient safety, and unlock differentiated value in a market where clinical and regulatory demands continue to evolve rapidly.

A mixed-methods, triangulated research approach combining primary stakeholder interviews, regulatory and technical analysis, and rigorous validation to produce actionable strategic insights

The research approach combines qualitative and quantitative methods to produce a robust, triangulated view of the blood processing and storage ecosystem. Primary research includes structured interviews with procurement leaders, clinical laboratory directors, transfusion service managers, and biomedical engineers to capture real-world operational pain points, adoption drivers, and procurement criteria. These insights are complemented by direct discussions with manufacturing and distribution executives to understand supply chain strategies, product roadmaps, and service models. Secondary research draws on regulatory filings, technical standards, manufacturer documentation, and peer-reviewed literature to validate product performance claims, sterilization and storage requirements, and technology specifications.

Data were synthesized through triangulation, where field interviews were cross-checked against publicly available regulatory documentation and technical white papers to ensure consistency. Segmentation mapping was applied across product type, end user, technology, and distribution channels to ensure that insights reflect operational realities across different care settings. Quality assurance measures included expert peer review and internal validation checks to identify contradictions and ensure methodological transparency. Limitations include variability in regional data transparency and the lag between regulatory changes and their operational impact; these were mitigated by prioritizing recent primary interviews and regulatory guidance documents. The methodology emphasizes actionable insights and is designed to support both strategic decision-making and tactical procurement actions.

Synthesis of operational, technological, and strategic themes emphasizing integrated solutions, procurement resilience, and the clinical imperative for traceable, automated workflows

The cumulative assessment highlights that blood processing and storage equipment is transitioning from commodity hardware toward integrated clinical infrastructure that combines automation, validated consumables, and digital traceability. Operational priorities increasingly center on reducing variability, safeguarding product integrity across the cold chain, and ensuring rapid access to spare parts and service. Procurement strategies must adapt to geopolitical and tariff-driven pressures by diversifying sourcing, qualifying regional suppliers, and embedding service and warranty protections into purchasing agreements. Technology trends point toward greater automation and interoperability, while segmentation nuances show that product and end-user specificity materially influence adoption timelines and value realization.

For stakeholders across the ecosystem, the path forward requires coordinated investments in equipment lifecycle management, workforce training, and data systems that support regulatory traceability and clinical decision-making. Manufacturers must continue to innovate around closed-system designs, validated consumables, and software-enabled workflow optimization. End users should prioritize total cost of ownership and clinical risk reduction when evaluating new equipment. By aligning commercial models with clinical outcomes and operational resilience, the sector can deliver safer, more efficient transfusion services and support the expanding needs of plasma and cellular therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing & Storage Equipment Market, by Product Type

  • 8.1. Apheresis Equipment
    • 8.1.1. Granulocyte Apheresis
    • 8.1.2. Plasma Apheresis
    • 8.1.3. Platelet Apheresis
  • 8.2. Blood Bags & Sets
    • 8.2.1. Double Blood Bag
    • 8.2.2. Single Blood Bag
    • 8.2.3. Triple And Quadruple Blood Bags
  • 8.3. Blood Collection Tubes
  • 8.4. Grouping Reagents
  • 8.5. Plasma Separation Equipment
  • 8.6. Storage Containers

9. Blood Processing & Storage Equipment Market, by Technology

  • 9.1. Automated
  • 9.2. Manual
  • 9.3. Semi Automated

10. Blood Processing & Storage Equipment Market, by End User

  • 10.1. Blood Banks
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Blood Processing & Storage Equipment Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online

12. Blood Processing & Storage Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Processing & Storage Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Processing & Storage Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Processing & Storage Equipment Market

16. China Blood Processing & Storage Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BioLife Solutions, Inc.
  • 17.6. Cerus Corporation
  • 17.7. Danaher Corporation
  • 17.8. Fresenius Kabi AG
  • 17.9. Grifols, S.A.
  • 17.10. Haemonetics Corporation
  • 17.11. PHC Holdings Corporation
  • 17.12. Sebia, Inc.
  • 17.13. StemCyte Inc.
  • 17.14. Stirling Ultracold
  • 17.15. Terumo Corporation
  • 17.16. Thermo Fisher Scientific Inc.
  • 17.17. ThermoGenesis Holdings, Inc.
  • 17.18. Vita 34 AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GRANULOCYTE APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GRANULOCYTE APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GRANULOCYTE APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLATELET APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLATELET APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLATELET APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DOUBLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DOUBLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DOUBLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SINGLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SINGLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SINGLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TRIPLE AND QUADRUPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TRIPLE AND QUADRUPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TRIPLE AND QUADRUPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUPING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUPING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUPING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY STORAGE CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY STORAGE CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY STORAGE CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 142. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 143. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 164. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 170. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 171. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)